At a glance
ClinicalIndex Comparison RecordN/ACompleted· 160 enrolled
Drug / intervention
Infrared illuminationdevice
Likely dose
Not stated in record
Key inclusion· 2
- ✓Children under 2 years old undergoing anesthesia procedures
- ✓ASA physical status 1, 2, or 3
Key exclusion· 3
- ✕Emergency procedures requiring anesthesia
- ✕ASA physical status 4
- ✕Patients with pre-existing IV access
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized Controlled Study of Efficacy of Infra Red Vein Illumination Versus Standard Technique
In Brief
A clinical study evaluating Infrared illumination for Difficult Intravenous Access. Completed, enrolled 160 participants across 1 site.
Detailed Summary
The objective of the study is to assess the efficacy of the vein visualization device AccuVein (AccuVein, Inc., Huntington, NY) in comparison to a standard technique for establishing intravenous (iv) access in the infant and toddler population (\<2years)
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDifficult Intravenous Access
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedJun 2017
Enrollment StartJul 2017
Primary CompletionOct 2020
TodayJul 2026
First PostedJun 8, 2017
Enrollment StartJul 10, 2017
Primary CompletionOct 29, 2020
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 9.1 years ago
Interventions
Infrared illuminationdevice
Infrared illumination of veins using the FDA approved AccuVein (AccuVein, Inc., Huntington, NY) device.